These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway. Wang Z; Yang L; Xia Y; Guo C; Kong L Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987 [TBL] [Abstract][Full Text] [Related]
3. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1. Wang TH; Wan JY; Gong X; Li HZ; Cheng Y Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407 [TBL] [Abstract][Full Text] [Related]
4. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship. Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086 [TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies. Gomes CM; van Paassen H; Romeo S; Welling MM; Feitsma RI; Abrunhosa AJ; Botelho MF; Hogendoorn PC; Pauwels E; Cleton-Jansen AM Nucl Med Biol; 2006 Oct; 33(7):831-40. PubMed ID: 17045162 [TBL] [Abstract][Full Text] [Related]
6. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633 [TBL] [Abstract][Full Text] [Related]
7. The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer. Zhang L; Li Y; Wang Q; Chen Z; Li X; Wu Z; Hu C; Liao D; Zhang W; Chen ZS Mol Cancer; 2020 Jan; 19(1):10. PubMed ID: 31952518 [TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells]. Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141 [TBL] [Abstract][Full Text] [Related]
9. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells. Li Y; Zhai Z; Li H; Wang X; Huang Y; Su X Chem Biol Interact; 2019 May; 305():98-104. PubMed ID: 30929998 [TBL] [Abstract][Full Text] [Related]
10. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506 [TBL] [Abstract][Full Text] [Related]
11. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway. Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650 [TBL] [Abstract][Full Text] [Related]
12. The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation. Imai Y; Yoshimori M; Fukuda K; Yamagishi H; Ueda Y Oncol Rep; 2012 Jun; 27(6):1703-9. PubMed ID: 22426819 [TBL] [Abstract][Full Text] [Related]
13. [The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells]. Wu Y; Guo L; Liu J; Liu R; Liu M; Chen J Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):1-7. PubMed ID: 24398307 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin. Jovelet C; Bénard J; Forestier F; Farinotti R; Bidart JM; Gil S Eur J Pharm Sci; 2012 Aug; 46(5):484-91. PubMed ID: 22484209 [TBL] [Abstract][Full Text] [Related]
15. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Gu J; Huang W; Wang X; Zhang J; Tao T; Zheng Y; Liu S; Yang J; Chen ZS; Cai CY; Li J; Wang H; Fan Y Mol Cancer; 2022 May; 21(1):112. PubMed ID: 35538494 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells. Zhang W; Ding W; Chen Y; Feng M; Ouyang Y; Yu Y; He Z Acta Biochim Biophys Sin (Shanghai); 2011 Aug; 43(8):647-53. PubMed ID: 21712253 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway. Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L Eur J Pharmacol; 2019 Sep; 858():172477. PubMed ID: 31228450 [TBL] [Abstract][Full Text] [Related]
18. [Role of PTEN protein in multidrug resistance of prostate cancer cells]. Sherbakova EA; Stromskaia TP; Rybalkina EIu; Kalita OV; Stavrovskaia AA Mol Biol (Mosk); 2008; 42(3):487-93. PubMed ID: 18702307 [TBL] [Abstract][Full Text] [Related]
19. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells. Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350 [TBL] [Abstract][Full Text] [Related]
20. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues]. Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]